Petronille Healthy Society is an IRS Section 501 (c) (3) organization

Sunil Pandit currently serves as the Lead Full Stack Developer at the Petronille Healthy Society, a role he has shaped through over a decade of experience building technology solutions for healthcare and social impact. His journey in rare disease innovation is both technically rigorous and deeply patient-centered, reflecting a sustained commitment to leveraging digital tools for communities affected by rare conditions.

Before his tenure at the Petronille Healthy Society, Pande spent seven years at a leading health technology firm, where he focused his engineering expertise on developing patient-facing platforms for underserved populations. This period was foundational to his career, establishing the architecture of his future work. At the health technology firm, Pande gained a profound understanding of how fragmented data systems and inaccessible interfaces compound the burdens on patients with rare diseases and their caregivers. His work during this time not only sharpened his technical acumen but also deepened his conviction that thoughtful code could be a form of advocacy.

Following his impactful service at the health technology firm, Pande joined the Petronille Healthy Society. His arrival coincided with a pivotal shift toward digital transformation in rare disease care. With his full stack expertise and systems-thinking approach, he quickly became a central figure in the organization, architecting platforms that have redefined how rare disease communities access information, connect with specialists, and participate in research.

At the Petronille Healthy Society, Pandit's role spans the entire development lifecycle, all aimed at democratizing rare disease innovation. He has been instrumental in building secure, scalable web applications that streamline patient registries, telehealth portals, and real-world data collection. His efforts are not confined to internal tools; his open-source contributions and API integrations have a global reach, enabling smaller patient organizations to adopt enterprise-grade technology without enterprise-level budgets. Pande's approach to his work is characterized by a deep commitment to user-centered design and iterative collaboration. He has been pivotal in bridging the gap between patients, clinicians, and data scientists by creating intuitive interfaces that translate complex medical workflows into accessible digital experiences. Under his leadership, cross-functional teams have delivered platforms that reduce diagnostic delays and accelerate research recruitment. His dedication to inclusive technology is evident in his relentless focus on accessibility standards, multilingual support, and mobile-first solutions for geographically isolated communities.

As a respected technologist, Pandit's contributions to rare disease innovation extend to the broader digital health ecosystem. His technical publications and conference presentations offer practical frameworks for building privacy-compliant, interoperable systems in low-resource settings. His engineering insights have informed standards for patient-owned data and have been adopted by advocacy networks seeking to modernize their infrastructure. In his current role, Pande continues to innovate at the intersection of machine learning and patient engagement, ensuring that algorithmic tools in rare disease care are transparent, equitable, and co-designed with the communities they serve. His work has been recognized through numerous industry awards and fellowships, reflecting his status as a pioneering developer and digital advocate in the rare disease field.

Sunil Panit Full Stack Developer

When Diplomacy Meets Science

From the halls of the U.S. Congress to remote village clinics, Duc Ntsomi's leadership spans the entire healthcare ecosystem, bridging the critical divide where global policy decisions intersect with local healthcare realities. Through strategic diplomacy, he is dismantling systemic barriers that have traditionally separated policymaking from frontline care delivery.

Currently, he is leading two transformative initiatives: advocating for rare disease inclusion on the G20 health agenda and forging innovative partnerships to implement AI-powered diagnostic tools and predictive treatment platforms in underserved communities. These efforts represent a new paradigm in global health equity, where cutting-edge technology and policy influence converge to create tangible solutions for historically neglected populations.

Thank you to our sponsors, donors and key partners